Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents

Autor:	Michael Bernimoulin, Frank van den Ouweland, Clémence Guidard, Magali Allard, Michela Schaeppi, Hulya Ozsahin
Rok vydání:	2020
Předmět:	Male Pediatrics medicine.medical_specialty Adolescent Anemia Ferric Compounds 03 medical and health sciences 0302 clinical medicine Medicine Humans Adverse effect Child Maltose Retrospective Studies biology Anemia Iron-Deficiency business.industry Infant Retrospective cohort study Hematology Iron deficiency medicine.disease Prognosis Iron Metabolism Disorders Ferritin Oncology Iron-deficiency anemia 030220 oncology & carcinogenesis Child Preschool Pediatrics Perinatology and Child Health Cohort biology.protein Administration Intravenous Female business 030215 immunology Cohort study Follow-Up Studies
Zdroj:	Pediatric bloodcancerREFERENCES. 67(10)
ISSN:	1545-5017
Popis:	OBJECTIVE The objective of this single-center observational study was to determine the clinical and hematologic responses to intravenous ferric carboxymaltose (FCM) in a cohort of pediatric patients with poor response to oral iron therapy. The occurrence of adverse events was systematically recorded for up to 96 hours after infusion. STUDY DESIGN A retrospective cohort of 144 consecutive patients aged 18 months to
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad449c244a14bdfd274090708cfec934 https://pubmed.ncbi.nlm.nih.gov/32969156 Zobrazit plný text záznamu Plný text